Dr. Barry Dworkin

Targeted gene-altering therapy reduced LDL-cholesterol levels by 50 per cent in patients with severely elevated cholesterol levels.

Medical Mythbusting Commentary for September 2, 2026

Source:
With the snip of a gene, scientists hope to erase high cholesterol for life

Reference:
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3

Related posts:

  1. Phase 1 targeted gene editing study demonstrates safety and reduction in LDL cholesterol levels through specific protein pathway
  2. Before screening toddlers cholesterol level to predict genetic risk of heart disease, long-term outcome and risk/benefit need to be fleshed out
  3. B.C. man cured of rare disease in world-first for new gene-editing technology
  4. Cancer treatments heading in fresh and creative directions